Tempest Therapeutics (TPST) Non-Current Debt (2017 - 2024)
Tempest Therapeutics (TPST) reported Non-Current Debt of $2.01 million for Q2 2024, down 73.2% from $7.48 million a year earlier and down 51.5% from the prior quarter.
Powered by 
Analysis
Tempest Therapeutics (TPST) Non-Current Debt (2017 - 2024) Analysis & Trends
At the end of FY2023, Tempest Therapeutics posted Non-Current Debt of $6.26 million, down 39.6% from FY2022.
- Non-Current Debt has a five-year compound annual growth rate of 74.9% (FY2018 to FY2023).
- By year, Non-Current Debt came in at $10.37 million in FY2022 (-31.2%), $15.07 million in FY2021 and $168,000 in FY2019 (-56.1%).
- The Q2 2024 figure ranks as the lowest quarterly Non-Current Debt since Q2 2020.
- Year over year, Non-Current Debt has now declined in each of the last nine quarters, with an average decline of 41.6% over the last eight quarters.
- The high point for year-over-year Non-Current Debt in five years was Q1 2022 (growth of 0.4%); the low point was Q2 2024 (a decline of 73.2%).
- Per Business Quant data, the three quarters before Q2 2024 came in at $4.14 million (Q1 2024), $6.26 million (Q4 2023) and $8.37 million (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Tempest Therapeutics | 4.09 Mn | -26.23 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 2.01 Mn |
| Mar 31, 2024 | 4.14 Mn |
| Dec 31, 2023 | 6.26 Mn |
| Sep 30, 2023 | 8.37 Mn |
| Jun 30, 2023 | 7.48 Mn |
| Mar 31, 2023 | 8.94 Mn |
| Dec 31, 2022 | 10.37 Mn |
| Sep 30, 2022 | 11.84 Mn |
| Jun 30, 2022 | 13.30 Mn |
| Mar 31, 2022 | 15.13 Mn |
| Dec 31, 2021 | 15.07 Mn |
| Sep 30, 2021 | 15.01 Mn |
| Jun 30, 2021 | 14.92 Mn |
| Mar 31, 2021 | 15.07 Mn |
| Jun 30, 2020 | 168,000.00 |
| Mar 31, 2020 | 110,000.00 |
| Dec 31, 2019 | 168,000.00 |
| Sep 30, 2019 | 218,000.00 |
| Jun 30, 2019 | 278,000.00 |
| Mar 31, 2019 | 325,000.00 |
API Access
Tempest Therapeutics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=TPST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "TPST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=TPST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();